Reactive oxygen species-targeted therapeutic interventions for atrial fibrillation

Frontiers in Physiology

Volumn 3 AUG, Issue , 2012, Pages

  Sovari, Ali A ^a   Dudley, Samuel C ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Antioxidants; Atrial fibrillation; Mitochondria; NADPH oxidase; Nitric oxide synthase; Therapy

Indexed keywords

EID: 84866506703     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00311     Document Type: Review

References (165)

1. Adachi, T., Weisbrod, R. M., Pimentel, D. R., Ying, J., Sharov, V. S., Schoneich, C., and Cohen, R. A. (2004). S-Glutathiolation by per-oxynitrite activates SERCA during arterial relaxation by nitric oxide. Nat. Med. 10, 1200-1207.
2. Ahmed, M. I., Gladden, J. D., Litovsky, S. H., Lloyd, S. G., Gupta, H., Inusah, S., Denney, T. Jr., Powell, P., McGiffin, D. C., and Dell'italia, L. J. (2010). Increased oxidative stress and cardiomyocyte myofib-rillar degeneration in patients with chronic isolated mitral regurgita-tion and ejection fraction >60%. J. Am. Coll. Cardiol. 55, 671-679.
3. Akhtar, M., Gilbert, C. J., and Shenasa, M. (1981). Effect of lidocaine on atrioventricular response via the accessory pathway in patients with Wolff-Parkinson-White syndrome. Circulation 63, 435-441.
4. Alvarez, B., and Radi, R. (2003). Peroxynitrite reactivity with amino acids and proteins. Amino Acids 25, 295-311.
5. Antoniades, C., Demosthenous, M., Reilly, S., Margaritis, M., Zhang, M. H., Antonopoulos, A., Marinou, K., Nahar, K., Jayaram, R., Tousoulis, D., Bakogiannis, C., Sayeed, R., Triantafyllou, C., Koumallos, N., Psarros, C., Miliou, A., Stefanadis, C., Channon, K. M., and Casadei, B. (2012). Myocardial redox state predicts in-hospital clinical outcome after cardiac surgery effects of short-term pre-operative statin treatment. J. Am. Coll. Cardiol. 59, 60-70.
6. Anzai, K., Ogawa, K., Kuniyasu, A., Ozawa, T., Yamamoto, H., and Nakayama, H. (1998). Effects of hydroxyl radical and sulfhydryl reagents on the open probability of the purified cardiac ryanodine receptor channel incorporated into planar lipid bilayers. Biochem. Biophys. Res. Commun. 249, 938-942.
7. Barford, D. (2004). The role of cys-teine residues as redox-sensitive regulatory switches. Curr. Opin. Struct. Biol. 14, 679-686.
8. Bellocci, F., Biasucci, L. M., Gensini, G. F., Padeletti, L., Raviele, A., Santini, M., Giubilato, G., Landolina, M., Biondi-Zoccai, G., Raciti, G., Sassara, M., Castro, A., Kheir, A., and Crea, E. (2007). Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. J. Cardiovasc. Med. (Hagerstown) 8, 293-299.
9. Beresewicz, A., and Horackova, M. (1991). Alterations in electrical and contractile behavior of isolated car-diomyocytes by hydrogen peroxide: possible ionic mechanisms. J. Mol. Cell Cardiol. 23, 899-918.
10. Billman, G. E., Harris, W S., Carnes, C. A., Adamson, P. B., Vanoli, E., and Schwartz, P. J. (2011). Dietary omega-3 fatty acids and susceptibility to ventricular fibrillation: lack of protection and a proar-rhythmic effect. Circ. Arrhythm. Electrophysiol. 300, H2288-H2299.
11. Blaustein, M. P., and Lederer, W. J. (1999). Sodium/calcium exchange: its physiological implications. Physiol. Rev. 79, 763-854.
12. Boldt, A., Wetzel, U., Weigl, J., Garbade, J., Lauschke, J., Hindricks, G., Kottkamp, H., Gummert, J. F., and Dhein, S. (2003). Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease. J. Am. Coll. Cardiol. 42, 1785-1792.
13. Bosch, R. F., Zeng, X., Grammer, J. B., Popovic, K., Mewis, C., and Kuhlkamp, V. (1999). Ionic mechanisms of electrical remodeling in human atrial fibrillation. Cardiovasc. Res. 44, 121-131.
14. Bouchie, J. L., Hansen, H., and Feener, E. P. (1998). Natriuretic factors and nitric oxide suppress plasmino-gen activator inhibitor-1 expression in vascular smooth muscle cells. Role of cGMP in the regulation of the plasminogen system. Arterioscler. Thromb. Vasc. Biol. 18, 1771-1779.
15. Brawn, K., and Fridovich, I. (1980). Superoxide radical and superoxide dismutases: threat and defense. Acta Physiol. Scand Suppl. 492, 9-18.
16. Brown, G. C., and Cooper, C. E. (1994). Nanomolar concentrations of nitric oxide reversibly inhibit synaptoso-mal respiration by competing with oxygen at cytochrome oxidase. FEBS Lett. 356, 295-298.
17. Brumell, J. H., Burkhardt, A. L., Bolen, J. B., and Grinstein, S. (1996). Endogenous reactive oxygen intermediates activate tyrosine kinases in human neutrophils. J. Biol. Chem. 271, 1455-1461.
18. Cai, H., Li, Z., Goette, A., Mera, F., Honeycutt, C., Feterik, K., Wilcox, J. N., Dudley, S. C. Jr., Harrison, D G., and Langberg, J. J. (2002). Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106, 2854-2858.
19. Cairns, J. A., Connolly, S. J., Roberts, R., and Gent, M. (1997). Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators. Lancet 349, 675-682.
20. Canton, M., Menazza, S., Sheeran, E L., Polverino de Laureto, P., Di Lisa, E, and Pepe, S. (2011). Oxidation of myofibrillar proteins in human heart failure. J. Am. Coll. Cardiol. 57, 300-309.
21. Carnes, C. A., Chung, M. K., Nakayama, T., Nakayama, H., Baliga, R. S., Piao, S., Kanderian, A., Pavia, S., Hamlin, R. L., McCarthy, P. M., Bauer, J. A., and Van Wagoner, D. R. (2001). Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ. Res. 89, E32-E38.
22. Carnes, C. A., Janssen, P. M., Ruehr, M. L., Nakayama, H., Nakayama, T., Haase, H., Bauer, J. A., Chung, M. K., Fearon, I. M., Gillinov, A. M., Hamlin, R. L., and Van Wagoner, D. R. (2007). Atrial glu-tathione content, calcium current, and contractility. J. Biol. Chem. 282, 28063-28073.
23. CAST Investigators. (1989). Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N. Engl. J. Med. 321, 406-412.
24. Cederbaum, A. I. (2001). Introduction-serial review: alcohol, oxidative stress and cell injury. Free Radic. Biol. Med. 31, 1524-1526.
25. Celermajer, D. S., Sorensen, K. E., Spiegelhalter, D. J., Georgakopoulos, D., Robinson, J., and Deanfield, J. E. (1994). Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 24, 471-476.
26. Chen, K., Thomas, S. R., and Keaney, J. E Jr. (2003). Beyond LDL oxidation: ROS in vascular signal trans-duction. Free Radic. Biol. Med. 35, 117-132.
27. Chesnais, J. M., Fischmeister, R., and Mery, P. E. (1999). Peroxynitrite is a positive inotropic agent in atrial and ventricular fibres of the frog heart. J. Physiol. 521 (Pt 2), 375-388.
28. Civelek, S., Seymen, O., Seven, A., Yigit, G., Hatemi, H., and Burcak, G. (2001). Oxidative stress in heart tissue of hyperthyroid and iron supplemented rats. J. Toxicol. Environ. Health A 64, 499-506.
29. Connor, K. M., Subbaram, S., Regan, K. J., Nelson, K. K., Mazurkiewicz, J. E., Bartholomew, P. J., Aplin, A. E., Tai, Y. T., Aguirre-Ghiso, J., Flores, S. C., and Melendez, J. A. (2005). Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J. Biol. Chem. 280, 16916-16924.
30. Coplen, S. E., Antman, E. M., Berlin, J. A., Hewitt, P., and Chalmers, T. C. (1990). Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardiover-sion. A meta-analysis of randomized control trials. Circulation 82, 1106-1116.
31. Cu, A., Ye, Q., Sarria, R., Nakamura, S., Guzman, J., and Costabel, U. (2009). N-acetylcysteine inhibits TNF-α, sTNFR, and TGF-β1 release by alveolar macrophages in idio-pathic pulmonary fibrosis in vitro. Sarcoidosis Vasc. Diffuse Lung Dis. 26, 147-154.
32. De Champlain, J., Wu, R., Girouard, H., Karas, M., EL Midaoui, A., Laplante, M. A., and Wu, L. (2004). Oxidative stress in hypertension. Clin. Exp. Hypertens. 26, 593-601.
33. De Vecchi, E., Pala, M. G., Di Credico, G., Agape, V., Paolini, G., Bonini, P. A., Grossi, A., and Paroni, R. (1998). Relation between left ventricular function and oxidative stress in patients undergoing bypass surgery. Heart 79, 242-247.
34. Di Wang, H., Hope, S., Du, Y., Quinn, M. T., Cayatte, A., Pagano, P. J., and Cohen, R. A. (1999). Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension 33, 1225-1232.
35. Dikalov, S. (2011). Cross talk between mitochondria and NADPH oxi-dases. Free Radic. Biol. Med. 51, 1289-1301.
36. Disertori, M., Latini, R., Barlera, S., Franzosi, M. G., Staszewsky, L., Maggioni, A. P., Lucci, D., Di, P. G., and Tognoni, G. (2009). Valsartan for prevention of recurrent atrial fibrillation. N. Engl. J. Med. 360, 1606-1617.
37. Doughan, A. K., Harrison, D. G., and Dikalov, S. I. (2008). Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction. Circ. Res. 102, 488-496.
38. Dremina, E. S., Sharov, V. S., Davies, M. J., and Schoneich, C. (2007). Oxidation and inactivation of SERCA by selective reaction of cysteine residues with amino acid peroxides. Chem. Res. Toxicol. 20, 1462-1469.
39. Dudley, S. C. Jr., Hoch, N. E., McCann, L. A., Honeycutt, C., Diamandopoulos, L., Fukai, T., Harrison, D. G., Dikalov, S. I., and Langberg, J. (2005). Atrial fibrillation increases production of superoxide by the left atrium and left atrial appendage: role of the NADPH and xanthine oxidases. Circulation 112, 1266-1273.
40. Duflo, F., Debon, R., Goudable, J., Chassard, D., and Allaouchiche, B. (2002). Alveolar and serum oxidative stress in ventilator-associated pneumonia. Br. J. Anaesth. 89, 231-236.
41. Eaton, P. (2006). Protein thiol oxidation in health and disease: techniques for measuring disulfides and related modifications in complex protein mixtures. Free Radic. Biol. Med. 40, 1889-1899.
42. Erickson, J. R., He, B. J., Grumbach, I. M., and Anderson, M. E. (2011). CaMKII in the cardiovascular system: sensing redox states. Physiol. Rev. 91, 889-915.
43. Fauconnier, J., Thireau, J., Reiken, S., Cassan, C., Richard, S., Matecki, S., Marks, A. R., and Lacampagne, A. (2010). Leaky RyR2 trigger ventricular arrhythmias in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U.S.A. 107, 1559-1564.
44. Freeman, B. A., White, C. R., Gutierrez, H., Paler-Martinez, A., Tarpey, M. M., and Rubbo, H. (1995). Oxygen radical-nitric oxide reactions in vascular diseases. Adv. Pharmacol. 34, 45-69.
45. Gautier, M., Zhang, H., and Fearon, I. M. (2008). Peroxynitrite formation mediates LPC-induced augmentation of cardiac late sodium currents. J. Mol. Cell Cardiol. 44, 241-251.
46. Gjesdal, K. (2009). Non-investigational antiarrhythmic drugs: long-term use and limitations. Expert Opin. DrugSaf.8, 345-355.
47. Goette, A., Schon, N., Kirchhof, P., Breithardt, G., Fetsch, T., Hausler, K. G., Klein, H. U., Steinbeck, G., Wegscheider, K., and Meinertz, T. (2012). Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Circ. Arrhythm. Electrophysiol. 5, 43-51.
48. Halliwell, B., Gutteridge, J. M., and Aruoma, O. I. (1987). The deoxyri-bose method: a simple "test-tube"assay for determination of rate constants for reactions of hydroxyl radicals. Anal. Biochem. 165, 215-219.
49. Hartnett, M. E., Stratton, R. D., Browne, R. W., Rosner, B. A., Lanham, R. J., and Armstrong, D. (2000). Serum markers of oxidative stress and severity of diabetic retinopathy. Diabetes Care 23, 234-240.
50. Hattori, Y., Atsushi, S., Hiroaki, F., and Toyama, J. (1997). Effects of cilaza-pril on ventricular arrhythmia in patients with congestive heart failure. Clin. Ther. 19, 481-486.
51. Hazen, S. L., SAvignon, A., Anderson, M. M., Hsu, F. F., and Heinecke, J. W. (1998a). Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to oxidize α-amino acids to a family of reactive aldehydes. Mechanistic studies identifying labile intermediates along the reaction pathway. J. Biol. Chem. 273, 4997-5005.
52. Hazen, S. L., Hsu, F. F., d'Avignon, A., and Heinecke, J. W. (1998b). Human neutrophils employ myeloperoxidase to convert α-amino acids to a battery of reactive aldehydes: a pathway for aldehyde generation at sites of inflammation. Biochemistry 37, 6864-6873.
53. Ide, T., Tsutsui, H., Kinugawa, S., Suematsu, N., Hayashidani, S., Ichikawa, K., Utsumi, H., Machida, Y., Egashira, K., and Takeshita, A. (2000). Direct evidence for increased hydroxyl radicals originating from superoxide in the failing myocardium. Circ. Res. 86, 152-157.
54. Iravanian, S., and Dudley, S. C. Jr. (2008). The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias. Heart Rhythm. 5, S12-S17.
55. Iravanian, S., Sovari, A. A., Lardin, H. A., Liu, H., Xiao, H. D., Dolmatova, E., Jiao, Z., Harris, B. S., Witham, E. A., Gourdie, R. G., Duffy, H. S., Bernstein, K. E., and Dudley, S. C. Jr. (2011). Inhibition of renin-angiotensin system (RAS) reduces ventricular tachycardia risk by altering connexin43. J. Mol. Med. (Berl.) 89, 677-687.
56. Irigoyen, M. C., Paulini, J., Flores, L. J., Flues, K., Bertagnolli, M., Moreira, E. D., Consolim-Colombo, E, Bello-Klein, A., and De, A. K. (2005). Exercise training improves baroreflex sensitivity associated with oxidative stress reduction in ovariectomized rats. Hypertension 46, 998-1003.
57. Issac, T. T., Dokainish, H., and Lakkis, N. M. (2007). Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data. J. Am. Coll. Cardiol. 50, 2021-2028.
58. Iwasaki, Y. K., Nishida, K., Kato, T., and Nattel, S. (2011). Atrial fibrillation pathophysiology: implications for management. Circulation 124, 2264-2274.
59. Jais, P., Haissaguerre, M., Shah, D. C., Chouairi, S., Gencel, L., Hocini, M., and Clementy, J. (1997). A focal source of atrial fibrillation treated by discrete radiofrequency ablation. Circulation 95, 572-576.
60. Jeong, E. M., Liu, M., Sturdy, M., Gao, G., Varghese, S. T., Sovari, A. A., and Dudley, S. C. (2012). Metabolic stress, reactive oxygen species, and arrhythmia. J. Mol. Cell Cardiol. 52, 454-463.
61. Jones, E. F., Calafiore, P., McNeil, J. J., Tonkin, A. M., and Donnan, G. A. (1996). Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiogra-phy is a potent risk factor for stroke. Am. J. Cardiol. 78, 425-429.
62. Jorde, U. P., Ennezat, P. V., Lisker, J., Suryadevara, V., Infeld, J., Cukon, S., Hammer, A., Sonnenblick, E. H., and Le Jemtel, T. H. (2000). Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure. Circulation 101, 844-846.
63. Julian, D. G., Camm, A. J., Frangin, G., Janse, M. J., Munoz, A., Schwartz, P. J., and Simon, P. (1997). Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators. Lancet 349, 667-674.
64. Kabe, Y., Ando, K., Hirao, S., Yoshida, M., and Handa, H. (2005). Redox regulation of NF-kappaB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid. Redox Signal. 7, 395-403.
65. 2+ channel. Mol. Pharmacol. 53, 497-503.
66. Khatib, R., Joseph, P., Briel, M., Yusuf, S., and Healey, J. (2012). Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials. Int. J. Cardiol. doi: 10.1016/j.ijcard.2012.02.009. [Epub ahead of print].
67. Kieken, F., Mutsaers, N., Dolmatova, E., Virgil, K., Wit, A. L., Kellezi, A., Hirst-Jensen, B. J., Duffy, H. S., and Sorgen, P. L. (2009). Structural and molecular mechanisms of gap junction remodeling in epicardial border zone myocytes following myocardial infarction. Circ. Res. 104, 1103-1112.
68. Kim, Y M., Kattach, H., Ratnatunga, C., Pillai, R., Channon, K. M., and Casadei, B. (2008). Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J. Am. Coll. Cardiol. 51, 68-74.
69. Kim, Y H., Lim, D. S., Lee, J. H., Shim, W. J., Ro, Y M., Park, G. H., Becker, K. G., Cho-Chung, Y S., and Kim, M. K. (2003). Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp. Mol. Med. 35, 336-349.
70. Kimura, Y., Sato, M., Kurotani, K., Nanri, A., Kawai, K., Kasai, H., Imaizumi, K., and Mizoue, T. (2012). PUFAs in serum cholesterol ester and oxidative DNA damage in Japanese men and women. Am. J. Clin. Nutr. 95, 1209-1214.
71. Kober, L., Torp-Pedersen, C., Carlsen, J. E., Bagger, H., Eliasen, P., Lyngborg, K., Videbaek, J., Cole, D. S., Auclert, L., and Pauly, N. C. (1995). A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group. N. Engl. I Med. 333, 1670-1676.
72. Kofler, S., Petrakopoulou, P., Grimm, C., Kaczmarek, I., Meiser, B. M., and Weis, M. (2008). Graft-infiltrating dendritic cells and coronary endothelial dysfunction after human heart transplantation. J. Heart Lung Transplant. 27, 387-393.
73. Koli, K., Myllarniemi, M., Keski-Oja, J., and Kinnula, V. L. (2008). Transforming growth factor-β activation in the lung: focus on fibro-sis and reactive oxygen species. Antioxid. RedoxSignal. 10, 333-342.
74. Kowey, P. R., Reiffel, J. A., Ellenbogen, K. A., Naccarelli, G. V., and Pratt, C. M. (2010). Efficacy and safety of prescription omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: a randomized controlled trial. JAMA 304, 2363-2372.
75. Krahn, A. D., Manfreda, J., Tate, R. B., Mathewson, F. A., and Cuddy, T. E. (1995). The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the Manitoba Follow-Up Study. Am. J. Med. 98, 476-484.
76. Kregel, K. C., and Zhang, H. J. (2007). An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 292, R18-R36.
77. Kukushkina, O. I., Fedotkina, L. K., Balashov, V. P., Balykova, L. A., and Sosunov, A. A. (1999). Effect of NO-synthetase inhibitor L-NAME on occlusive and reperfusion arrhythmias in cats. Biull Eksp. Biol Med. 127, 509-511.
78. Kulagina, N. V., and Michael, A. C. (2003). Monitoring hydrogen peroxide in the extracellular space of the brain with amperometric microsensors. Anal Chem. 75, 4875-4881.
79. Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., and Sadoshima, J. (2010). NADPH oxi-dase 4 (Nox4) is a major source of oxidative stress in the failing heart. Proc. Natl Acad. Sci. U.S.A. 107, 15565-15570.
80. Lambrinoudaki, I. V., Augoulea, A., Christodoulakos, G. E., Economou, E. V., Kaparos, G., Kontoravdis, A., Papadias, C., and Creatsas, G. (2009). Measurable serum markers of oxidative stress response in women with endometriosis. Fertil. Steril. 91, 46-50.
81. Levine, R. L. (2002). Carbonyl modified proteins in cellular regulation, aging, and disease. Free Radic. Biol. Med. 32, 790-796.
82. Li, N., Frigerio, F., and Maechler, P. (2008). The sensitivity of pancreatic β-cells to mitochondrial injuries triggered by lipotoxicity and oxidative stress. Biochem. Soc. Trans. 36, 930-934.
83. Liberman, M., Bassi, E., Martinatti, M. K., Lario, F. C., Wosniak, J. Jr., Pomerantzeff, P. M., and Laurindo, F. R. (2008). Oxidant generation predominates around calcifying foci and enhances progression of aortic valve calcification. Arterioscler. Thromb. Vasc. Biol. 28, 463-470.
84. Liu, M., Liu, H., and Dudley, S. C. Jr. (2010). Reactive oxygen species originating from mitochondria regulate the cardiac sodium channel. Circ. Res. 107, 967-974.
85. Liu, R. M., Liu, Y., Forman, H. J., Olman, M., and Tarpey, M. M. (2004). Glutathione regulates transforming growth factor-β-stimulated collagen production in fibroblasts. Am. J. Physiol Lung Cell Mol. Physiol. 286, L121-L128.
86. Liu, T., Korantzopoulos, P., Shehata, M., Li, G., Wang, X., and Kaul, S. (2011). Prevention of atrial fibrillation with omega-3 fatty acids: a meta-analysis of randomised clinical trials. Heart 97, 1034-1040.
87. Lu, L., Chen, S. S., Zhang, J. Q., Ramires, F. J., and Sun, Y. (2004). Activation of nuclear factor-kappaB and its proinflammatory mediator cascade in the infarcted rat heart. Biochem. Biophys. Res. Commun. 321, 879-885.
88. Ma, J. H., Luo, A. T., and Zhang, P. H. (2005). Effect of hydrogen peroxide on persistent sodium current in guinea pig ventricular myocytes. Acta Pharmacol. Sin. 26, 828-834.
89. Maan, A., Shaikh, A. Y., Mansour, M., Ruskin, J. N., and Heist, E. K. (2011). Complications from catheter ablation of atrial fibrillation: a systematic review. Crit. Path. Cardiol. 10, 76-83.
90. Madamanchi, N. R., Vendrov, A., and Runge, M. S. (2005). Oxidative stress and vascular disease. Arterioscler. Thromb. Vasc. Biol. 25, 29-38.
91. 2+ current: interaction of reactive oxygen species and β-adrenergic signaling. Cardiovasc. Res. 67, 578-580.
92. Mihm, M. J., Yu, F., Carnes, C. A., Reiser, P. J., McCarthy, P. M., Van Wagoner, D. R., and Bauer, J. A. (2001). Impaired myofibril-lar energetics and oxidative injury during human atrial fibrillation. Circulation 104, 174-180.
93. Milei, J., Ferreira, R., Grana, D. R., and Boveris, A. (2001). Oxidative stress and mitochondrial damage in coronary artery bypass graft surgery: effects of antioxidant treatments. Compr. Ther. 27, 108-116.
94. Miller, J. D., Chu, Y., Brooks, R. M., Richenbacher, W. E., Pena-Silva, R., and Heistad, D. D. (2008). Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans. J. Am. Coll. Cardiol. 52, 843-850.
95. Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., and Tsang, T. S. (2006). Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114, 119-125.
96. Molyneux, C. A., Glyn, M. C., and Ward, B. J. (2002). Oxidative stress and cardiac microvascular structure in ischemia and reperfusion: the protective effect of antioxidant vitamins. Microvasc. Res. 64, 265-277.
97. Morel, F., Doussiere, J., and Vignais, P. V. (1991). The superoxide-generating oxidase of phagocytic cells. Physiological, molecular and pathological aspects. Eur. J. Biochem. 201, 523-546.
98. Morganroth, J., and Goin, J. E. (1991). Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis. Circulation 84, 1977-1983.
99. Morita, N., Lee, J. H., Xie, Y., Sovari, A., Qu, Z., Weiss, J. N., and Karagueuzian, H. S. (2011). Suppression of re-entrant and multifocal ventricular fibrillation by the late sodium current blocker ranolazine. J. Am. Coll. Cardiol. 57, 366-375.
100. Morita, N., Sovari, A. A., Xie, Y., Fishbein, M. C., Mandel, W. J., Garfinkel, A., Lin, S. F., Chen, P. S., Xie, L. H., Chen, F., Qu, Z., Weiss, J. N., and Karagueuzian, H. S. (2009). Increased susceptibility of aged hearts to ventricular fibrillation during oxidative stress. Am. J. Physiol. Heart Circ. Physiol. 297, H1594-H1605.
101. 2+-pump dysfunction in rat cardiomyocytes briefly exposed to hydroxyl radicals. Free Radic. Biol. Med. 22, 37-47.
102. Murrell, G. A., Francis, M. J., and Bromley, L. (1990). Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265, 659-665.
103. Negi, S., Sovari, A. A., and Dudley, S. C. Jr. (2010). Atrial fibrillation: the emerging role of inflammation and oxidative stress. Cardiovasc. Hematol Disord. Drug Targets. 10, 262-268.
104. Neuman, R. B., Bloom, H. L., Shukrullah, I., Darrow, L. A., Kleinbaum, D., Jones, D. P., and Dudley, S. C. Jr. (2007). Oxidative stress markers are associated with persistent atrial fibrillation. Clin. Chem. 53, 1652-1657.
105. Nishijima, Y., Sridhar, A., Bonilla, I., Velayutham, M., Khan, M., Terentyeva, R., Li, C., Kuppusamy, P., Elton, T. S., Terentyev, D., Gyorke, S., Zweier, J. L., Cardounel, A. J., and Carnes, C. A. (2011). Tetrahydrobiopterin depletion and NOS2 uncoupling contribute to heart failure-induced alterations in atrial electrophysiology. Cardiovasc. Res. 91, 71-79.
106. O'Rourke, B., Cortassa, S., and Aon, M. A. (2005). Mitochondrial ion channels: gatekeepers of life and death. Physiology (Bethesda.) 20, 303-315.
107. Ohki, R., Yamamoto, K., Ueno, S., Mano, H., Misawa, Y., Fuse, K., Ikeda, U., and Shimada, K. (2005). Gene expression profiling of human atrial myocardium with atrial fibrillation by DNA microarray analysis. Int. J. Cardiol. 102, 233-238.
108. Ovechkin, A. V., Lominadze, D., Sedoris, K. C., Robinson, T. W., Tyagi, S. C., and Roberts, A. M. (2007). Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions. Arch. Physiol. Biochem. 113, 1-12.
109. Pu, M., Akhand, A. A., Kato, M., Hamaguchi, M., Koike, T., Iwata, H., Sabe, H., Suzuki, H., and Nakashima, I. (1996). Evidence of a novel redox-linked activation mechanism for the Src kinase which is independent of tyrosine 527-mediated regulation. Oncogene 13, 2615-2622.
110. Radomski, M. W., Palmer, R. M., and Moncada, S. (1987). Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets. Br. J.Pharmacol. 92, 181-187.
111. Reilly, S. N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon, K. M., Alp, N. J., Schotten, U., and Casadei, B. (2011a). Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124, 1107-1117.
112. Reilly, S. N., Jayaram, R., Nahar, K., Antoniades, C., Verheule, S., Channon, K. M., Alp, N. J., Schotten, U., and Casadei, B. (2011b). Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation 124, 1107-1117.
113. Riis, B., and Poulsen, H. E. (2005). "DNA repair: mechanisms and measurments, "in Oxidant and Antioxidants Defense Systems, ed T. Grune (Berlin: Springer), 152-169.
114. Sam, F., Kerstetter, D. L., Pimental, D. R., Mulukutla, S., Tabaee, A., Bristow, M. R., Colucci, W. S., and Sawyer, D. B. (2005). Increased reactive oxygen species production and functional alterations in antioxidant enzymes in human failing myocardium. J. Card Fail. 11, 473-480.
115. Santana, L. F., Nunez-Duran, H., Dilly, K. W., and Lederer, W. J. (2005). Sodium current and arrhythmogenesis in heart failure. Heart Fail. Clin. 1, 193-205.
116. + currents in atrial fibrillation new drug target or just an epiphenomenon? J. Am. Coll. Cardiol. 55, 2343-2345.
117. Schotten, U., Verheule, S., Kirchhof, P., and Goette, A. (2011). Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol. Rev. 91, 265-325.
118. Schramm, A., Matusik, P., Osmenda, G., and Guzik, T. J. (2012). Targeting NADPH oxidases in vascular pharmacology. Vascul. Pharmacol. 56, 216-231.
119. Seddon, M., Looi, Y. H., and Shah, A. M. (2007). Oxidative stress and redox signalling in cardiac hypertrophy and heart failure. Heart 93, 903-907.
120. Sesso, H. D., Buring, J. E., Christen, W. G., Kurth, T., Belanger, C., MacFadyen, J., Bubes, V., Manson, J. E., Glynn, R. J., and Gaziano, J. M. (2008). Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA 300, 2123-2133.
121. Shan, J., Kushnir, A., Betzenhauser, M. J., Reiken, S., Li, J., Lehnart, S. E., Lindegger, N., Mongillo, M., Mohler, P. J., and Marks, A. R. (2010). Phosphorylation of the ryanodine receptor mediates the cardiac fight or flight response in mice.J. Clin. Invest. 120, 4388-4398.
122. Shang, L. L., Sanyal, S., Pfahnl, A. E., Jiao, Z., Allen, J., Liu, H., and Dudley, S. C. Jr. (2008). NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II. Am. J. Physiol. Cell Physiol. 294, C372-C379.
123. Shimano, M., Shibata, R., Inden, Y., Yoshida, N., Uchikawa, T., Tsuji, Y., and Murohara, T. (2009). Reactive oxidative metabolites are associated with atrial conduction disturbance in patients with atrial fibrillation. Heart Rhythm 6, 935-940.
124. 2+ influx through L-type voltage-dependent calcium channels by hydroxyl radical in mouse cerebral cortical neurons. Brain Res. Mol. Brain Res. 92, 12-18.
125. Siebels, J., Cappato, R., Ruppel, R., Schneider, M. A., and Kuck, K. H. (1993). Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investig. Am. 1 Cardiol. 72, 109F-113F.
126. Singh, S. N., Fletcher, R. D., Fisher, S. G., Singh, B. N., Lewis, H. D., Deedwania, P. C., Massie, B. M., Colling, C., and Lazzeri, D. (1995). Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N. Engl. J. Med. 333, 77-82.
127. Soliman, D., Hamming, K. S., Matemisz, L. C., and Light, P. E. (2009). Reactive oxygen species directly modify sodium-calcium exchanger activity in a splice variant-dependent manner. J. Mol. Cell Cardiol. 47, 595-602.
128. Sommer, D., Coleman, S., Swanson, S. A., and Stemmer, P. M. (2002). Differential susceptibilities of serine/threonine phosphatases to oxidative and nitrosative stress. Arch. Biochem. Biophys. 404, 271-278.
129. Song, Y., Cook, N. R., Albert, C. M., Van, D. M., and Manson, J. E. (2009). Effects of vitamins C and E and β-carotene on the risk of type 2 diabetes in women at high risk of cardiovascular disease: a random ized controlled trial. Am. J. Clin. Nutr. 90, 429-437.
130. Song, Y., Shryock, J. C., Wagner, S., Maier, L. S., and Belardinelli, L. (2006). Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction. J. Pharmacol. Exp. Ther. 318, 214-222.
131. Sorescu, D., Weiss, D., Lassegue, B., Clempus, R. E., Szocs, K., Sorescu, G. P., Valppu, L., Quinn, M. T., Lambeth, J. D., Vega, J. D., Taylor, W R., and Griendling, K. K. (2002). Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 105, 1429-1435.
132. + currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium. J. Am. Coll. Cardiol. 55, 2330-2342.
133. Sovari, A. A. (2011). Antioxidant therapy for atrial fibrillation: what is the next step? Cardiol. Res. Pract. 2011, 429537.
134. Sovari, A. A., and Dudley, S. C. (2010). "Atrial fibrillation and oxidative stress, "in Studies in Cardiovascular Disorders, eds H. Sauer, M. S. Ajay, and F. R. Laurindo (New York, NY: Humana Press), 373-389.
135. Sovari, A. A., Bonini, M. G., and Dudley, S. C. (2011a). Effective antioxidant therapy for the management of arrhythmia. Expert. Rev. Cardiovasc. Ther. 9, 797-800.
136. Sovari, A. A., Iravanian, S., Dolmatova, E., Jiao, Z., Liu, H., Zandieh, S., Kumar, V., Wang, K., Bernstein, K. E., Bonini, M. G., Duffy, H. S., and Dudley, S. C. (2011b). Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death. J. Am. Coll. Cardiol. 58, 2332-2339.
137. Sovari, A. A., Iravanian, S., Mitchell, D., Jeong, E. M., Gu, L., Bonini, M. G., and Dudley, S. C. (2011c). Mitochondria-targeted antioxidant, mito-TEMPO, prevents angiotensin II mediated connexin 43 remodeling and sudden cardiac death. J. Investig. Med. 59, 692-730.
138. Sovari, A. A., Jeong, E. M., Dolmatova, E., Tan, A. Y., Zandieh, S., Liu, M., Gu, L., and Arasu, D. (201 1d). c-Src tyrosine kinase mediates the effect of mitochondrial oxidative stress on gap junctional remodeling and ventricular tachycardia. Circulation 124, A14385.
139. Sovari, A. A., Jiao, Z., Dolmatova, E., Kumar, V., Wang, K., Bonini, M. G., Duffy, H., and Dudley, S. C. (2010). c-Src tyrosine kinase is a potential therapeutic target to prevent angiotensin-II mediated connexin43 remodeling and ventricular arrhythmia. Circulation 122, A17524.
140. Sovari, A. A., Morita, N., and Karagueuzian, H. S. (2008). Apocynin: a potent NADPH oxi-dase inhibitor for the management of atrial fibrillation. Redox. Rep. 13, 242-245.
141. Sovari, A. A., Shroff, A., and Kocheril, A. G. (2012). Postinfarct cardiac remodeling and the substrate for sudden cardiac death: role of oxidative stress and myocardial fibrosis. Expert. Rev. Cardiovasc. Ther. 10, 267-270.
142. Sridhar, A., Nishijima, Y., Terentyev, D., Khan, M., Terentyeva, R., Hamlin, R. L., Nakayama, T., Gyorke, S., Cardounel, A. J., and Carnes, C. A. (2009). Chronic heart failure and the substrate for atrial fibrillation. Cardiovasc. Res. 84, 227-236.
143. Stadtman, E. R., Moskovitz, J., and Levine, R. L. (2003). Oxidation of methionine residues of proteins: biological consequences. Antioxid. Redox Signal. 5, 577-582.
144. Stamler, J. S., and Hausladen, A. (1998). Oxidative modifications in nitrosative stress. Nat. Struct. Biol. 5, 247-249.
145. Suzuki, K., Ito, Y., Ochiai, J., Kusuhara, Y., Hashimoto, S., Tokudome, S., Kojima, M., Wakai, K., Toyoshima, H., Tamakoshi, K., Watanabe, Y., Hayakawa, N., Maruta, M., Watanabe, M., Kato, K., Ohta, Y., and Tamakoshi, A. (2003). Relationship between obesity and serum markers of oxidative stress and inflammation in Japanese. Asian Pac. J. Cancer Prev. 4, 259-266.
146. Suzuki, Y J., and Forman, H. J., and Sevanian, A. (1997). Oxidants as stimulators of signal transduction. FreeRadic. Biol. Med. 22, 269-285.
147. Tarpey, M. M., and Fridovich, I. (2001). Methods of detection of vascular reactive species: nitric oxide, superoxide, hydrogen peroxide, and peroxynitrite. Circ. Res. 89, 224-236.
148. Tarpey, M. M., Wink, D. A., and Grisham, M. B. (2004). Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am. J. Physiol. Regul. Integr. Comp. Physiol. 286, R431-R444.
149. Thomas, G. P., Sims, S. M., Cook, M. A., and Karmazyn, M. (1998). Hydrogen peroxide-induced stimulation of L-type calcium current in guinea pig ventricular myocytes and its inhibition by adenosine A1 receptor activation. J. Pharmacol. Exp. Ther. 286, 1208-1214.
150. Tong, X., Evangelista, A., and Cohen, R. A. (2010). Targeting the redox regulation of SERCA in vascular physiology and disease. Curr. Opin. Pharmacol. 10, 133-138.
151. Toyofuku, T., Yabuki, M., Otsu, K., Kuzuya, T., Tada, M., and Hori, M. (1999). Functional role of c-Src in gap junctions of the cardiomyo-pathic heart. Circ. Res. 85, 672-681.
152. Tu, H., Liu, J., Zhu, Z., Zhang, L., Pipinos, I. I., and Li, Y. L. (2012). Mitochondria-derived superox-ide and voltage-gated sodium channels in baroreceptor neurons from chronic heart-failure rats. J. Neurophysiol. 107, 591-602.
153. Uchida, K. (2000). Role of reactive aldehyde in cardiovascular diseases. Free Radic. Biol. Med. 28, 1685-1696.
154. van de Wal, R. M., Plokker, H. W., Lok, D. J., Boomsma, F., van der Horst, F. A., van Veldhuisen, D. J., van Gilst, W. H., and Voors, A. A. (2006). Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. Int. J. Cardiol. 106, 367-372.
155. Van Wagoner, D. R. (2007). Recent insights into the pathophysiology of atrial fibrillation. Semin. Thorac. Cardiovasc. Surg. 19, 9-15.
156. Van Wagoner, D. R. (2008). Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target. J. Cardiovasc. Pharmacol. 52, 306-313.
157. Vassalle, C., Petrozzi, L., Botto, N., Andreassi, M. G., and Zucchelli, G. C. (2004). Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J. Intern. Med. 256, 308-315.
158. Waldo, A. L., Camm, A. J., deRuyter, H., Friedman, P. L., MacNeil, D. J., Pauls, J. F., Pitt, B., Pratt, C. M., Schwartz, P. J., and Veltri, E. P. (1996). Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol. Lancet 348, 7-12.
159. Weissbach, H., Etienne, F., Hoshi, T., Heinemann, S. H., Lowther, W. T., Matthews, B., St, J. G., Nathan, C., and Brot, N. (2002). Peptide methionine sulfoxide reductase: structure, mechanism of action, and biological function. Arch. Biochem. Biophys. 397, 172-178.
160. Wong, C. M., Marcocci, L., Liu, L., and Suzuki, Y. J. (2010). Cell signaling by protein carbonylation and decar-bonylation. Antioxid. Redox Signal. 12, 393-404.
161. Wosniak, J. Jr., Santos, C. X., Kowaltowski, A. J., and Laurindo, E R. (2009). Cross-talk between mitochondria and NADPH oxi-dase: effects of mild mitochondrial dysfunction on angiotensin II-mediated increase in Nox isoform expression and activity in vascular smooth muscle cells. Antioxid. Redox Signal. 11, 1265-1278.
162. Yamauchi, M., Nakano, H., Maekawa, J., Okamoto, Y., Ohnishi, Y., Suzuki, T., and Kimura, H. (2005). Oxidative stress in obstructive sleep apnea. Chest 127, 1674-1679.
163. Yoshizumi, M., Abe, J., Haendeler, J., Huang, Q., and Berk, B. C. (2000). Src and Cas mediate JNK activation but not ERK1/2 and p38 kinases by reactive oxygen species. J. Biol. Chem. 275, 11706-11712.
164. 2+ exchange and not by its antioxidant effects. Circ. Res. 70, 804-811.
165. Zinkevich, N. S., and Gutterman, D. D. (2011). ROS-induced ROS release in vascular biology: redox-redox signaling. Am. J. Physiol. Heart Circ. Physiol. 301, H647-H653.